2019台灣生技月 Bio Taiwan 生物科技大展

2019 台灣生技月 南港展覽館

講師

Session 6

Date: 25 July (Thursday)  14:00 – 17:30
Venue: 3F, Bldg. A, CTBC Financial Park, Ballroom B
Session 6
Protein Drugs and Combination Products

Protein drugs continue to dominate the drug development landscape, with more than 2,700 in development as of mid-2017. All signs point to continued increases in the approval and updates of biologics—including biosimilars—in particularly for cancer, rare diseases, and autoimmune conditions. This session will cover the full spectrum of topics important to this industry, including working with CROs, manufacturing pitfalls and regulatory strategies, and new solutions to reduce costs. Don’t miss this session’s coverage of the latest advances in biologics drug delivery that are addressing these issues